Mark Doerr's most recent trade in MedAvail Holdings Inc was a trade of 125,000 Stock Options (Right to Buy) done . Disclosure was reported to the exchange on Aug. 18, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
MedAvail Holdings Inc | Mark Doerr | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Aug 2023 | 125,000 | 125,000 | - | - | Stock Options (Right to Buy) | |
MedAvail Holdings Inc | Mark Doerr | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Aug 2023 | 125,000 | 125,000 | - | - | Restricted Stock Units | |
MedAvail Holdings Inc | Mark Doerr | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.31 per share. | 03 Mar 2023 | 72,785 | 188,701 | - | 0.3 | 22,651 | Common Stock |
MedAvail Holdings Inc | Mark Doerr | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.33 per share. | 03 Mar 2023 | 20,773 | 261,486 | - | 0.3 | 6,776 | Common Stock |
MedAvail Holdings Inc | Mark Doerr | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 282,259 | 564,516 | - | - | Restricted Stock Units | |
MedAvail Holdings Inc | Mark Doerr | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 282,259 | 282,259 | - | 0 | Common Stock | |
MedAvail Holdings Inc | Mark Doerr | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2022 | 1,173,127 | 1,173,127 | - | - | Stock Option (Right to Buy) | |
MedAvail Holdings Inc | Mark Doerr | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2022 | 846,775 | 846,775 | - | - | Restricted Stock Units |